Cargando…

Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser(129) in Biological Samples

[Image: see text] Synucleinopathies are a group of neurodegenerative diseases including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). These diseases are characterized by the aggregation and deposition of α-synuclein (α-syn) in Lewy bodies (LBs) in PD a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutta, Suman, Hornung, Simon, Taha, Hash Brown, Biggs, Karl, Siddique, Ibrar, Chamoun, Lea M., Shahpasand-Kroner, Hedieh, Lantz, Carter, Herrera-Vaquero, Marcos, Stefanova, Nadia, Loo, Joseph A., Bitan, Gal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080651/ https://www.ncbi.nlm.nih.gov/pubmed/36920792 http://dx.doi.org/10.1021/acschemneuro.2c00676

Ejemplares similares

A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition
por: Taha, Hash Brown, et al.
Publicado: (2022)

Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
por: Arawaka, Shigeki, et al.
Publicado: (2017)

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
por: Dutta, Suman, et al.
Publicado: (2023)

Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
por: Nübling, Georg Sebastian, et al.
Publicado: (2014)

Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces
por: Sasaki, Asuka, et al.
Publicado: (2015)

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
por: Swirski, Marta, et al.
Publicado: (2014)

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein
por: Bentea, Eduard, et al.
Publicado: (2015)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
por: Pérez-Revuelta, B I, et al.
Publicado: (2014)

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
por: Chau, Kai-Yin, et al.
Publicado: (2013)

α-Synuclein serine129 phosphorylation – the physiology of pathology
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

Death-associated Protein Kinase 1 Phosphorylates α-Synuclein at Ser129 and Exacerbates Rotenone-induced Toxic Aggregation of α-Synuclein in Dopaminergic SH-SY5Y Cells
por: Shin, Woo Hyun, et al.
Publicado: (2020)

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
por: Hornung, Simon, et al.
Publicado: (2020)

In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129
por: Weston, Leah J., et al.
Publicado: (2021)

Lysine-selective molecular tweezers are cell penetrant and concentrate in lysosomes
por: Li, Zizheng, et al.
Publicado: (2021)

Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
por: Elfarrash, Sara, et al.
Publicado: (2021)

Single point mutations at the S129 residue of α-synuclein and their effect on structure, aggregation, and neurotoxicity
por: Pandit, Esha, et al.
Publicado: (2023)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

ELISA method to detect α-synuclein oligomers in cell and animal models
por: Lassen, Louise Berkhoudt, et al.
Publicado: (2018)

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
por: Shahpasand-Kroner, Hedieh, et al.
Publicado: (2018)

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA
por: Bétemps, Dominique, et al.
Publicado: (2014)

Trends and Advances in Electrochemiluminescence Nanobiosensors
por: Rizwan, Mohammad, et al.
Publicado: (2018)

Determination of Hydroxychloroquine by Cathodic Electrochemiluminescence
por: Yagov, V. V., et al.
Publicado: (2022)

Electrochemiluminescence with semiconductor (nano)materials
por: Zhao, Yiran, et al.
Publicado: (2022)

Luciferase‐free Luciferin Electrochemiluminescence
por: Belotti, Mattia, et al.
Publicado: (2022)

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
por: Landeck, Natalie, et al.
Publicado: (2016)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
por: Oueslati, Abid
Publicado: (2016)

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Elsholz, Lea, et al.
Publicado: (2021)

Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
por: Lashuel, Hilal A., et al.
Publicado: (2022)

Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay
por: Arlinghaus, Ryan, et al.
Publicado: (2023)

EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
por: Kovac, Marc, et al.
Publicado: (2020)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

ARL6IP5 Ameliorates α-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12
por: Siddique, Ibrar, et al.
Publicado: (2023)

Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties
por: Dent, Sydney E., et al.
Publicado: (2021)

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
por: Domenicale, Chiara, et al.
Publicado: (2022)

Evaluation of α‐synuclein in CNS‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis
por: Taha, Hash Brown, et al.
Publicado: (2023)

Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q7e5cn7la2hc3v8l2d309u4nl4